| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 51 |
| 1 | OMEPRAZOLE MAGNESIUM | 7 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 6 |
| 3 | ERGOCALCIFEROL | 6 |
| 4 | LETROZOLE | 6 |
| 5 | OMEPRAZOLE | 6 |
| 6 | PREDNISONE | 6 |
| 7 | CAPECITABINE | 5 |
| 8 | LISINOPRIL | 5 |
| 9 | RISEDRONATE SODIUM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 6 | 0.0022 |
| 1 | CEDAZURIDINE AND DECITABINE | 2 | 0.0020 |
| 2 | NAFCILLIN SODIUM | 1 | 0.0011 |
| 3 | MIGLUSTAT | 1 | 0.0009 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | METHYLNALTREXONE BROMIDE | 1 | 0.0007 |
| 6 | ALENDRONATE SODIUM | 51 | 0.0005 |
| 7 | IVOSIDENIB | 1 | 0.0005 |
| 8 | DASATINIB | 4 | 0.0004 |
| 9 | VUTRISIRAN | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 12 |
| 1 | Kinase Inhibitor [EPC] | 10 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 4 | Aromatase Inhibitor [EPC] | 7 |
| 5 | Benzodiazepine [EPC] | 7 |
| 6 | Proton Pump Inhibitor [EPC] | 7 |
| 7 | Vitamin D [EPC] | 7 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 6 |
| 9 | Provitamin D2 Compound [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Enzyme Stabilizer [EPC] | 1 | 0.0009 |
| 1 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 2 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Calcitonin [EPC] | 1 | 0.0003 |
| 4 | Cannabinoid [EPC] | 2 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 6 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Aromatase Inhibitor [EPC] | 7 | 0.0001 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |